Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis
⚠︎Low quality — median 22 genes per cell. Datasets below 100 genes/cell may not produce meaningful analysis results.